Late disseminated Lyme disease (Stage 3) occurs months to years after initial Borrelia burgdorferi infection and is characterized primarily by Lyme arthritis (the hallmark manifestation in North America) and, less commonly, late neuroborreliosis or acrodermatitis chronica atrophicans (predominantly European). [1-3] Serology is invariably positive at this stage, making IgG seronegativity essentially exclusionary. [4]
1. History
- Joint symptoms: Intermittent or persistent monoarticular/oligoarticular swelling, especially of the knee; episodes may last weeks to months with pain-free intervals [2][5]
- Timing: Onset typically >6 months after tick bite; many patients have no recollection of prior erythema migrans or tick exposure [2][6]
- Neurologic symptoms: Subtle cognitive difficulties (memory, concentration), peripheral neuropathy (paresthesias, radicular pain), or rarely progressive encephalomyelitis [4][7]
- Skin changes (European): Slowly progressive bluish-red discoloration and skin atrophy on extensor surfaces of extremities (acrodermatitis chronica atrophicans) [4]
- Important negatives: Absence of fever in most adults with Lyme arthritis (fever more common in children); absence of prior EM rash does not exclude diagnosis [4][8]
2. Alarm Features
- High-degree AV block (PR >300 ms), syncope, or hemodynamic instability — suggests Lyme carditis (typically early disseminated, but consider if concurrent) [4]
- Rapidly progressive encephalomyelitis: Spastic paraparesis, ataxia, bladder dysfunction, cranial neuropathies — rare but serious late CNS involvement [6-7]
- Synovial WBC >100,000/µL: While Lyme arthritis typically has lower counts (~46,000–60,000 in children, lower in adults), very high counts should prompt evaluation for septic arthritis [4]
- New focal neurologic deficits or signs of raised intracranial pressure
- Persistent arthritis despite two courses of antibiotics (oral + IV) — suggests postantibiotic Lyme arthritis requiring rheumatology referral [4][9]
3. Medications
First-line treatment for Lyme arthritis: [4][8]
- Doxycycline 100 mg PO BID × 28 days
- Amoxicillin 500 mg PO TID × 28 days
- Cefuroxime axetil 500 mg PO BID × 28 days
If no/minimal response to oral therapy: [9-10]
Late neuroborreliosis: [4][9]
Acrodermatitis chronica atrophicans: [8]
Postantibiotic (refractory) Lyme arthritis: [4]
- NSAIDs ± intra-articular corticosteroids
- DMARDs (hydroxychloroquine, methotrexate, TNF inhibitors)
- Arthroscopic synovectomy if refractory
Contraindicated/Cautions
- Macrolides (azithromycin) are second-line only — higher treatment failure rates [2]
- Prolonged antibiotics (>8 weeks including IV course) are not recommended for persistent symptoms without objective disease activity [4][9]
- Doxycycline: avoid in pregnancy and children <8 years (though recent guidelines have relaxed pediatric restrictions for short courses)
4. Diet
- No specific dietary triggers or restrictions for late Lyme disease
- Adequate hydration and anti-inflammatory diet may support general well-being during treatment
- Patients on prolonged doxycycline should take medication with food/water and avoid dairy products within 2 hours of dosing to optimize absorption
5. Review of Systems
- MSK: Joint swelling, stiffness, Baker's cyst, migratory arthralgias [5]
- Neuro: Memory impairment, difficulty concentrating, paresthesias, radicular pain, facial weakness [4][7]
- Derm: Skin atrophy or discoloration on extremities (ACA) [4]
- Cardiac: Palpitations, presyncope, syncope, exercise intolerance (if concurrent carditis) [4]
- Constitutional: Fatigue, malaise — common but nonspecific
- Psych: Depression, sleep disturbance — may be associated or comorbid
6. Collateral History and Family History
- Tick exposure history: Outdoor activities, endemic area residence/travel (Northeast, upper Midwest US; northern Europe) [4]
- Prior Lyme diagnosis or treatment: Previous EM rash, prior antibiotic courses, incomplete treatment
- Travel history: European travel raises possibility of ACA or Bannwarth syndrome [5]
- Family history: No hereditary component, but household members with similar exposures may also be at risk
- HLA-DR4 and HLA-DR2: Associated with increased risk of postantibiotic Lyme arthritis (immune-mediated) [4]
7. Risk Factors
- Residence in or travel to endemic areas (CT, DE, ME, MD, MA, MN, NH, NJ, NY, PA, RI, VT, VA, WI account for 95% of US cases) [11]
- Outdoor occupational or recreational exposure (hiking, gardening, hunting)
- Untreated or inadequately treated early Lyme disease — ~60% of untreated patients progress to disseminated disease [5]
- Peak transmission: May through September (nymphal tick activity)
- Male sex — higher incidence of carditis [4]
- Bimodal age distribution: children 5–14 and adults 50–64 [12]
8. Differential Diagnosis
- Septic arthritis: Higher synovial WBC (mean ~128,000 vs ~46,000–60,000 in Lyme), more likely febrile, positive Gram stain/culture [4]
- Reactive arthritis: Post-infectious, often with urethritis/conjunctivitis; seronegative for Lyme
- Rheumatoid arthritis: Symmetric polyarthritis, RF/anti-CCP positive; can be misdiagnosed as "chronic Lyme" [4]
- Gout/pseudogout: Crystal-positive on synovial fluid analysis; may coexist with Lyme arthritis in adults [4]
- Osteoarthritis: Degenerative changes on imaging, no effusion typically
- Juvenile idiopathic arthritis (in children): Important mimic of Lyme arthritis in endemic areas
- Multiple sclerosis: White matter lesions on MRI; late Lyme encephalomyelitis can mimic MS [6-7]
- Other tick-borne coinfections: Anaplasmosis, babesiosis — consider if atypical features or poor treatment response [2]
9. Past Medical History
- Prior Lyme disease episodes or treatment (seroreactivity may persist for years, complicating interpretation) [4]
- History of immunosuppression (rare cause of seronegative late Lyme) [4]
- Pre-existing joint disease (OA, crystal arthropathy) — may alter presentation [4]
- Prior tick bites or prophylactic doxycycline use
- Autoimmune conditions — relevant for differential and for postantibiotic arthritis management
10. Physical Exam
- Knee effusion: Most common finding — large, warm, often painless or mildly tender joint effusion; typically monoarticular [2][5]
- Baker's cyst: Posterior knee fullness from large effusion [5]
- Quadriceps atrophy: In chronic/refractory cases [4]
- Neurologic exam: Assess cranial nerves (especially VII), sensation (stocking-glove neuropathy), deep tendon reflexes, gait, cognitive screening
- Skin: Inspect extensor surfaces for violaceous discoloration or tissue-paper thin atrophic skin (ACA) [4]
- Cardiac: Auscultate for irregular rhythm, bradycardia; check for signs of heart failure if carditis suspected
- Vital signs: Usually normal in isolated Lyme arthritis; fever more common in pediatric patients [4][8]
11. Lab Studies
- Two-tiered serology (standard or modified algorithm): [2][4][13]
- First tier: EIA/ELISA screening
- Second tier: IgG Western blot (≥5 of 10 bands positive) or second EIA
- IgG is invariably positive in late Lyme disease — IgM-only reactivity without IgG should prompt questioning the diagnosis [4]
- Synovial fluid analysis (if arthrocentesis performed):
- WBC typically 25,000–60,000/µL, neutrophil predominant [4]
- Gram stain and culture to exclude septic arthritis
- B. burgdorferi PCR on synovial fluid: 71–100% sensitivity pre-treatment; useful in seropositive patients with prior exposure to improve diagnostic specificity [4]
- CSF analysis (if late neuroborreliosis suspected): [13]
- Lymphocytic pleocytosis, elevated protein, normal glucose
- CSF/serum antibody index for intrathecal antibody production
- ESR/CRP: Often elevated [11]
- CBC, hepatic panel: May show mild transaminase elevation [11]
- Crystal analysis of synovial fluid to exclude concurrent gout/pseudogout [4]
12. Imaging
- Joint radiographs: Usually normal early; may show soft tissue swelling or effusion; chronic cases may show erosive changes
- Ultrasound: Useful for confirming joint effusion, Baker's cyst, and guiding arthrocentesis
- MRI of the joint: Synovial thickening, effusion; helpful to assess for synovial proliferation in refractory cases
- MRI brain/spine (if late neuroborreliosis suspected): White matter T2/FLAIR hyperintensities, enhancement with contrast [6]
- Imaging is not required for straightforward Lyme arthritis with positive serology and typical presentation
13. Special Tests
- B. burgdorferi PCR on synovial fluid or tissue — moderate-high sensitivity (71–100%) pre-treatment; note that PCR may remain positive weeks to months post-treatment and does not necessarily indicate active infection [4]
- CSF/serum antibody index — gold standard for confirming intrathecal antibody production in late neuroborreliosis [13]
- Nerve conduction studies/EMG: If peripheral neuropathy suspected — typically shows axonal polyneuropathy [7]
- Neuropsychological testing: May document cognitive deficits in Lyme encephalopathy [4][7]
- Avoid: Borrelia culture of blood (sensitivity only ~8% in Lyme arthritis), antibody testing on synovial fluid (false positives), and unvalidated "Lyme panels" [4]
14. ECG
While Lyme carditis is primarily an early disseminated manifestation, ECG should be obtained if cardiac symptoms are present or if the patient has not been previously evaluated:
- AV block is the hallmark — ranges from first-degree to complete heart block; degree can fluctuate rapidly over minutes to hours [4][14]
- PR interval >300 ms: Threshold for hospital admission with continuous monitoring [4]
- Third-degree AV block: Most common ECG finding in Lyme carditis (77% of cases) [14]
- ST depression or T-wave inversions (inferolateral leads) in ~60% of patients with myocardial involvement [14]
- Permanent pacemaker is NOT indicated — AV block resolves with antibiotics in >94% of cases, typically within 1–2 weeks [14-15]
The following figure illustrates the characteristic stepwise resolution of high-degree AV block in a patient with Lyme carditis treated with antibiotics:
15. Assessment
Late disseminated Lyme disease represents a treatable infection that, if recognized, responds well to appropriate antibiotic therapy in most cases. Key clinical pearls:
- Lyme arthritis is the most common late manifestation in North America, occurring on average >6 months after tick bite [2]
- Serology is highly sensitive (95–100%) at this stage — a negative IgG essentially excludes the diagnosis [4]
- Up to 23% of Lyme arthritis patients may develop postantibiotic (immune-mediated) arthritis requiring non-antibiotic management [4]
- Post-treatment Lyme disease syndrome (persistent fatigue, pain, cognitive symptoms without objective findings) occurs in a subset of patients; prolonged antibiotics have shown no benefit in RCTs [4][16]
- Late neuroborreliosis with encephalomyelitis is uncommon but more frequently reported in Europe [6]
16. Treatment Plan
Initial management of Lyme arthritis
- Confirm diagnosis with two-tiered serology (IgG positive) [4]
- Start oral antibiotics × 28 days: doxycycline 100 mg BID (preferred), amoxicillin 500 mg TID, or cefuroxime 500 mg BID [4][8]
- NSAIDs for symptomatic relief of joint pain and swelling
- Arthrocentesis if septic arthritis cannot be excluded [4]
If inadequate response to initial oral course: [9-10]
Postantibiotic Lyme arthritis (persistent synovitis after oral + IV courses): [4][9]
- NSAIDs ± intra-articular corticosteroids → DMARDs (hydroxychloroquine, methotrexate, TNF inhibitors) → arthroscopic synovectomy
- Antibiotic therapy >8 weeks (including one IV course) is not expected to provide additional benefit [4]
- Rheumatology referral recommended
Late neuroborreliosis: [4][9-10]
- IV ceftriaxone 2 g/day or oral doxycycline 200 mg/day × 14–21 days
- Route selection based on severity, ability to tolerate oral medication, and compliance
Post-treatment Lyme disease syndrome: [4][9-10]
- Symptomatic management (pain, fatigue, cognitive rehabilitation)
- No additional antibiotics recommended (strong recommendation, moderate-quality evidence)
17. Disposition
Outpatient management is appropriate for
- Uncomplicated Lyme arthritis — oral antibiotics with close follow-up [4][8]
- Isolated cranial nerve palsy without meningitis [9]
- Mild peripheral neuropathy
Admission criteria: [4][9]
- Lyme carditis with PR >300 ms, high-degree AV block, or hemodynamic instability → continuous ECG monitoring
- Symptomatic myocarditis or heart failure
- Severe neurologic involvement (encephalomyelitis, meningitis with altered mental status)
- Inability to tolerate oral medications requiring IV antibiotics
Specialist consultation triggers
- Rheumatology: Persistent arthritis after two antibiotic courses; consideration of DMARDs [4][9]
- Neurology: Late neuroborreliosis, encephalopathy, or peripheral neuropathy [4]
- Cardiology: Lyme carditis with conduction abnormalities [14]
- Infectious disease: Diagnostic uncertainty, treatment failure, or suspected coinfection
18. Follow Up / Return Precautions
- Follow-up at 4–6 weeks after completing antibiotics to assess arthritis response; resolution may take 1–3 months after treatment [4]
- Repeat arthrocentesis if effusion persists or worsens
- Serology should not be used to monitor treatment response — antibodies persist for years after successful treatment [4]
- Return precautions — seek immediate care for:
- New or worsening joint swelling despite completing antibiotics
- Syncope, presyncope, palpitations, or chest pain
- New neurologic symptoms (weakness, numbness, cognitive decline, facial droop)
- High fever suggesting alternative or concurrent infection
- Counsel patients that post-treatment symptoms (fatigue, arthralgias, cognitive fog) may persist for weeks to months but typically improve over time; prolonged antibiotics are not beneficial [4][16]
- Tick bite prevention counseling for future exposure (DEET, permethrin-treated clothing, tick checks) [11]
References
1. Lyme Borreliosis. — Strle F, Strle K, Marques A, et al. Nature Reviews. Disease Primers. 2026.
2. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review. — Sanchez E, Vannier E, Wormser GP, Hu LT. The Journal of the American Medical Association. 2016.
3. Lyme disease. — National Library of Medicine (MedlinePlus) 2018.
4. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. — Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2021.
5. Tickborne Diseases of the United States: A Reference Manual for Healthcare Providers Sixth Edition. — Nancy Shadick MD MPH, Nancy Maher MPH, Dennis Hoak MD United States Centers for Disease Control and Prevention (2022). 2022.
6. Lyme Borreliosis. — Stanek G, Wormser GP, Gray J, Strle F. Lancet. 2012.
7. Chronic Neurologic Manifestations of Lyme Disease. — Logigian EL, Kaplan RF, Steere AC. The New England Journal of Medicine. 1990.
8. Lyme Disease: Updated Recommendations From the IDSA, AAN, and ACR. — Williams AL, Bevan J, Arnold MJ. American Family Physician. 2021.
9. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. — Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Arthritis & Rheumatology. 2021.
10. Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. — Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Neurology. 2021.
11. Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Management of Tick-Borne Illness in the United States. — Ho BM, Davis HE, Forrester JD, et al. Wilderness & Environmental Medicine. 2021.
12. Optimisation of Dose Level and Vaccination Schedule for the VLA15 Lyme Borreliosis Vaccine Candidate Among Healthy Adults: Two Randomised, Observer-Blind, Placebo-Controlled, Multicentre, Phase 2 Studies. — Bézay N, Wagner L, Kadlecek V, et al. The Lancet. Infectious Diseases. 2024.
13. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
14. Diagnosis and Treatment of Lyme Carditis: JACC Review Topic of the Week. — Yeung C, Baranchuk A. Journal of the American College of Cardiology. 2019.
15. 2018 ACC/AHA/HRS Guideline on The Evaluation and Management Of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Kusumoto FM, Schoenfeld MH, Barrett C, et al. Journal of the American College of Cardiology. 2019.
16. Lyme Borreliosis: Diagnosis and Management. — Kullberg BJ, Vrijmoeth HD, van de Schoor F, Hovius JW. BMJ. 2020.